Welcome to the ACT Member Network


ACT hosts quarterly webinars on current topics in toxicology, including primarily drug and chemical safety assessments. Presenters are experts in their field, with backgrounds in goverment, industry, or academia. The goal of the webinars are to provide accessible education on topics on toxicology to ACT members and, more broadly, members of the toxicology community worldwide. Participation requires registration and most webinars are free. Members and nonmembers may take advantage of past webinars by accessing the archives.

Date File
2020-02-16 Safety Assessment of Metabolites in Drug Development: Current Perspective Details
2020-01-07 Realizing the Full Potential of Membership with the American College of Toxicology Details
2019-10-18 Immunological Assessments of Viral Vectors Expressing Multiple Cytokine Transgenes in Nonclinical... Details
2019-07-31 Early Toxicology Studies—From Design to Dose Selection: What You Need to Know Details
2019-05-28 A Regulatory and Industry Perspective on the Introduction and Application of GLP Regulations... Details
2019-04-17 Nonclinical Abuse Liability Testing of Biologics Details
2018-12-21 Safety Assessment of Monoclonal Antibodies for Immunosuppressants and Anti-Inflammatory Agents Details
2018-09-21 The Veterinary Pathologist’s Role in the 3Rs Details
2018-06-01 Preclinical Considerations for Cell-Based Immunotherapies Details
2018-03-08 Preparing for Regulatory Interactions: How Much is Enough? Details
2017-12-13 Animal Models of Disease for Nonclinical Safety Assessment: Pharmaceutical Industry Survey Details
2017-09-21 Nonclinical Safety Assessment of Prophylactic and Therapeutic Vaccines Details
2017-04-10 Reproduction, Development, and Pathology: Finding Common Ground Details
2017-03-10 Exploring Certifications in General Toxicology: An Introduction to ABT/ERT/ATS Certification Details
2017-01-30 Your Job Search: Cover Letters, CVs, and Interviews—Oh My! Details
2016-10-26 Adversity in Nonclinical Reporting: Myths, Legends, and Reality Details
2016-09-09 Influence of the Microbiota in Drug Development and Preclinical Studies Details
2016-05-18 Regulatory and Scientific Challenges in Biosimilar Development: Nonclinical Considerations Details
2016-02-08 Impurities: The Good, the Bad, and the Ugly Details
2015-12-21 Pathology Peer Review and the OECD Guidance on the GLP Requirements: A Review of the Review Details
2015-09-22 Applications of iPS-Cell Derived Tissues in Safety Assessment Details
2015-05-26 Computational Toxicology: A Useful Tool for Hazard Identification and Risk Assessment? Details
2015-01-29 Juvenile Animal Studies: Regulatory and Industry Perspectives Details
2014-12-04 Implications for Tox/TK When ISR Fails Details
2014-10-31 Mini-Pig Use in Safety Assessments during Drug Development Details
2014-10-31 Carcinogenicity Assessment of Biologics Details
2014-10-31 Preparing for Nonclinical eData Regulatory Submissions to the US FDA—“SEND” and Beyond Details
2014-10-31 Practical Nanotoxicology Details
2014-10-31 Fundamental Approaches to Immunotoxicity Assessment in Preclinical Safety Studies Details
2014-10-31 Safety Testing of Metabolites Details
2014-10-31 Understanding Developmental and Reproductive Toxicity Studies Details
2014-10-30 Presentation on ACT's 2014 Strategic Planning Map Details